CORDA Investment Management LLC.increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 43.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC).The institutional investor owned 187,000 shares of the financial services provider’s stock after purchasing an additional 56,453 shares during the period.CME Group makes up 4.0% of CORDA Investment Management LLC.’s portfolio, making the stock its 3rd biggest position.CORDA Investment Management LLC.owned approximately 0.05% of CME Group worth $32,334,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in CME.Norges Bank bought a new position in shares of CME Group during the 4th quarter valued at about $645,732,000.
BlackRock Inc.lifted its holdings in shares of CME Group by 4.6% during the 1st quarter.BlackRock Inc.now owns 26,645,530 shares of the financial services provider’s stock valued at $4,607,281,000 after purchasing an additional 1,179,970 shares in the last quarter.FMR LLC lifted its holdings in shares of CME Group by 14.7% during the 4th quarter.
FMR LLC now owns 7,774,032 shares of the financial services provider’s stock valued at $1,560,404,000 after purchasing an additional 996,023 shares in the last quarter.Parnassus Investments CA lifted its stake in CME Group by 25.0% in the 4th quarter.Parnassus Investments CA now owns 3,556,924 shares of the financial services provider’s stock valued at $713,946,000 after acquiring an additional 711,558 shares in the last quarter.
Finally, Renaissance Technologies LLC lifted its stake in CME Group by 31.6% in the 4th quarter.
Renaissance Technologies LLC now owns 2,134,418 shares of the financial services provider’s stock valued at $428,420,000 after acquiring an additional 512,199 shares in the last quarter.Institutional investors and hedge funds own 85.08% of the company’s stock.Get CME Group alerts:
Shares of CME Group stock traded down $2.57 on Thursday, reaching $178.25.639,557 shares of the company were exchanged, compared to its average volume of 1,764,328.
CME Group Inc has a one year low of $131.80 and a one year high of $225.36.The company has a market capitalization of $64.46 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 4.32 and a beta of 0.32.The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.13.The company has a 50-day moving average of $180.88 and a 200 day moving average of $196.49.
CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, April 29th.The financial services provider reported $2.33 earnings per share for the quarter, topping analysts’ consensus estimates of $2.23 by $0.10.
The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.48 billion.CME Group had a return on equity of 10.15% and a net margin of 45.79%.The firm’s revenue was up 29.0% compared to the same quarter last year.
During the same period in the previous year, the firm earned $1.62 EPS.Analysts predict that CME Group Inc will post 7.73 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 25th.
Investors of record on Wednesday, June 10th will be issued a dividend of $0.85 per share.This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.91%.
The ex-dividend date of this dividend is Tuesday, June 9th.CME Group’s payout ratio is presently 50.00%.
In other CME Group news, COO Julie Holzrichter sold 3,061 shares of the company’s stock in a transaction on Friday, February 28th.The stock was sold at an average price of $203.37, for a total value of $622,515.57.Following the transaction, the chief operating officer now directly owns 37,284 shares of the company’s stock, valued at approximately $7,582,447.08.The sale was disclosed in a legal filing with the SEC, which is accessible through this link .Also, insider Julie Winkler sold 5,620 shares of the company’s stock in a transaction on Monday, February 24th.The shares were sold at an average price of $210.97, for a total value of $1,185,651.40.Following the completion of the transaction, the insider now directly owns 25,114 shares in the company, valued at $5,298,300.58.
The disclosure for this sale can be found here .Insiders have sold a total of 11,692 shares of company stock worth $2,350,147 over the last three months.
1.20% of the stock is owned by insiders.
Several equities research analysts have commented on the company.Cfra cut their target price on CME Group from $218.00 to $205.00 and set a “hold” rating on the stock in a research note on Wednesday, April 29th.Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $182.00 target price on the stock in a research note on Monday, April 6th.Rosenblatt Securities restated a “sell” rating and issued a $157.00 target price on shares of CME Group in a research note on Friday, April 3rd.Deutsche Bank cut their target price on CME Group from $198.00 to $191.00 and set a “buy” rating on the stock in a research note on Friday, May 15th.Finally, UBS Group boosted their target price on CME Group from $222.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, April 30th.Three analysts have rated the stock with a sell rating, eight have given a hold rating and seven have given a buy rating to the company.
The company has a consensus rating of “Hold” and a consensus price target of $193.67.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide.It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
See Also: What is required to own or exchange cryptocurrency?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).Receive News & Ratings for CME Group analysts’ ratings for CME Group and related companies daily email newsletter .
«.